SFS
PCRX icon

Sowell Financial Services’s Pacira BioSciences PCRX Stock Holding History

Sowell Financial Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,929
Closed -$122K – 2071
2021
Q1 		$122K Sell
1,929
-572
-23% -$40.9K ﹤0.01% 1278
2020
Q4 		$150K Sell
2,501
-2
-0.1% -$117 0.01% 977
2020
Q3 		$150K Buy
2,503
+205
+9% +$11.9K 0.01% 828
2020
Q2 		$121K Sell
2,298
-657
-22% -$27.5K 0.01% 910
2020
Q1 		$99K Buy
2,955
+2,944
+26,764% +$122K 0.01% 842
2019
Q4 		$0 Sell
11
-20
-65% -$849 ﹤0.01% 2615
2019
Q3 		$1K Buy
+31
New +$1.24K ﹤0.01% 2287

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Sowell Financial Services's PCRX Position: Q2 2021 in Review

Sowell Financial Services sold out of Pacira BioSciences (PCRX) in Q2 2021, closing a stake of 1,929 shares — an estimated $122K sold.

Sowell Financial Services first reported a position in PCRX in Q3 2019 and held it in 7 quarters. The position peaked at $150K in Q4 2020. 262 funds tracked by Wall St. Rank hold PCRX as of Q2 2021.

  • Sowell Financial Services reported no remaining Pacira BioSciences position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,929 Pacira BioSciences shares in Q2 2021, an estimated $122K.
  • Sowell Financial Services first reported a position in Pacira BioSciences in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Pacira BioSciences position peaked at $150K in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.